Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vance G Fowler

Showing results (221-230 of 426) with videos related to

Pageof 43
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|January 8, 2024
In-patient evolution of a high-persister <i>Escherichia coli</i> strain with reduced in vivo antibiotic susceptibilityJoshua B Parsons, Ashelyn E Sidders, Amanda Z Velez, et al.
Journal of Clinical Microbiology|December 14, 2007
Genotypic characteristics of Staphylococcus aureus isolates from a multinational trial of complicated skin and skin structure infectionsSteven J Campbell, Hitesh S Deshmukh, Charlotte L Nelson, et al.
Clinical Journal of the American Society of Nephrology : CJASN|January 2, 2009
Outcomes of Staphylococcus aureus infection in hemodialysis-dependent patientsYanhong Li, Joëlle Y Friedman, Betsy F O'Neal, et al.
Antimicrobial Agents and Chemotherapy|November 17, 2022
Safety of Ceftazidime-Avibactam in Combination with Aztreonam (COMBINE) in a Phase I, Open-Label Study in Healthy Adult VolunteersThomas P Lodise, J Nicholas O'Donnell, Shruti Raja, et al.
Biorxiv : the Preprint Server for Biology|November 18, 2024
A host-directed adjuvant resuscitates and sensitizes intracellular bacterial persisters to antibioticsKuan-Yi Lu, Xiangbo Yang, Matthew J G Eldridge, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|January 18, 2024
Feasibility of tracking invasive Escherichia coli disease among older adults in a community setting: A prospective observational studyJoachim Doua, Miquel Ekkelenkamp, Theo Verheij, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 20, 2024
Distinct Clinical Endpoints of Staphylococcus aureus Bacteraemia Complicate Assessment of OutcomeClark D Russell, Karla Berry, George Cooper, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 19, 2006
Use of vancomycin or first-generation cephalosporins for the treatment of hemodialysis-dependent patients with methicillin-susceptible Staphylococcus aureus bacteremiaMartin E Stryjewski, Lynda A Szczech, Daniel K Benjamin, et al.
JAMA Network Open|May 23, 2020
Consensus on Language for Advance Informed Consent in Health Care-Associated Pneumonia Clinical Trials Using a Delphi ProcessAmy Corneli, Sara B Calvert, John H Powers, et al.
Infection Control and Hospital Epidemiology|July 16, 2005
Clinical outcomes and costs due to Staphylococcus aureus bacteremia among patients receiving long-term hemodialysisJohn J Engemann, Joelle Y Friedman, Shelby D Reed, et al.
Pageof 43

Showing results (221-230 of 426) with videos related to

Sort By:
Pageof 43
Proceedings of the National Academy of Sciences of the United States of America|January 8, 2024
In-patient evolution of a high-persister <i>Escherichia coli</i> strain with reduced in vivo antibiotic susceptibilityJoshua B Parsons, Ashelyn E Sidders, Amanda Z Velez, et al.
Journal of Clinical Microbiology|December 14, 2007
Genotypic characteristics of Staphylococcus aureus isolates from a multinational trial of complicated skin and skin structure infectionsSteven J Campbell, Hitesh S Deshmukh, Charlotte L Nelson, et al.
Clinical Journal of the American Society of Nephrology : CJASN|January 2, 2009
Outcomes of Staphylococcus aureus infection in hemodialysis-dependent patientsYanhong Li, Joëlle Y Friedman, Betsy F O'Neal, et al.
Antimicrobial Agents and Chemotherapy|November 17, 2022
Safety of Ceftazidime-Avibactam in Combination with Aztreonam (COMBINE) in a Phase I, Open-Label Study in Healthy Adult VolunteersThomas P Lodise, J Nicholas O'Donnell, Shruti Raja, et al.
Biorxiv : the Preprint Server for Biology|November 18, 2024
A host-directed adjuvant resuscitates and sensitizes intracellular bacterial persisters to antibioticsKuan-Yi Lu, Xiangbo Yang, Matthew J G Eldridge, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|January 18, 2024
Feasibility of tracking invasive Escherichia coli disease among older adults in a community setting: A prospective observational studyJoachim Doua, Miquel Ekkelenkamp, Theo Verheij, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 20, 2024
Distinct Clinical Endpoints of Staphylococcus aureus Bacteraemia Complicate Assessment of OutcomeClark D Russell, Karla Berry, George Cooper, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 19, 2006
Use of vancomycin or first-generation cephalosporins for the treatment of hemodialysis-dependent patients with methicillin-susceptible Staphylococcus aureus bacteremiaMartin E Stryjewski, Lynda A Szczech, Daniel K Benjamin, et al.
JAMA Network Open|May 23, 2020
Consensus on Language for Advance Informed Consent in Health Care-Associated Pneumonia Clinical Trials Using a Delphi ProcessAmy Corneli, Sara B Calvert, John H Powers, et al.
Infection Control and Hospital Epidemiology|July 16, 2005
Clinical outcomes and costs due to Staphylococcus aureus bacteremia among patients receiving long-term hemodialysisJohn J Engemann, Joelle Y Friedman, Shelby D Reed, et al.
Pageof 43